{"id":263,"name":"Adam Feuerstein","first_name":"Adam","url":"","description":"Adam Feuerstein is a senior writer and biotech columnist for STAT, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a cohost of STAT's weekly <a href=\"https:\/\/www.statnews.com\/signup\/readout-loud\/\">\"The Readout LOUD\" podcast<\/a> and the author of the weekly newsletter  <a href=\"https:\/\/www.statnews.com\/signup\/scorecard\/\">Adam's Biotech Scorecard.<\/a> In 2022, a series of stories by Feuerstein and STAT colleagues that examined Biogen and the controversial approval of its Alzheimer's disease drug Aduhelm won the George Polk Award for medical reporting, and NIHCM and SABEW journalism prizes. Prior to joining STAT in 2017, Feuerstein was a longtime biotech reporter at TheStreet, a biotech analyst for a New York investment fund, and covered the early internet and dot-com era as a San Francisco-based technology reporter. You can reach Adam on Signal at stataf.54.","link":"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/","slug":"adam-feuerstein","avatar_urls":{"24":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-24x24.png","48":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-48x48.png","96":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-96x96.png"},"meta":{"stat_user_show_on_staff_page":true,"stat_user_round_avatar":"645371","stat_user_staff_avatar":"644400","stat_user_team":"editorial","stat_user_team_business":"","stat_user_team_editorial":"biotech-pharma","stat_user_email":"","stat_user_short_bio":"Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast <a href=\"https:\/\/www.statnews.com\/category\/readout-loud\/\">The Readout Loud<\/a> and author of the newsletter <a href=\"https:\/\/www.statnews.com\/signup\/scorecard\/\">Adam's Biotech Scorecard.<\/a> You can reach Adam on Signal at stataf.54.","stat_user_title":"Senior Writer, Biotech"},"simple_local_avatar":{"media_id":644316,"full":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile.png","192":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-192x192.png","96":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-96x96.png","64":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-64x64.png","32":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-32x32.png","500":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-500x500.png","50":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-50x50.png","25":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-25x25.png","48":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-48x48.png","24":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-24x24.png","2048":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile.png","1024":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile.png","128":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-128x128.png","52":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-52x52.png","26":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-26x26.png","18":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-18x18.png","36":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-36x36.png"},"author_id":7294,"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.5 (Yoast SEO v26.5) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Adam Feuerstein, Senior Biotech Writer<\/title>\n<meta name=\"description\" content=\"Adam Feuerstein is a senior writer, biotech columnist and podcast host for STAT. He covers Wall Street and biotechnology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"profile\" \/>\n<meta property=\"og:title\" content=\"Adam Feuerstein\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/\" \/>\n<meta property=\"og:site_name\" content=\"STAT\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-1000x576.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@statnews\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"ProfilePage\",\"@id\":\"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/\",\"url\":\"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/\",\"name\":\"Adam Feuerstein, Senior Biotech Writer\",\"isPartOf\":{\"@id\":\"https:\/\/www.statnews.com\/#website\"},\"description\":\"Adam Feuerstein is a senior writer, biotech columnist and podcast host for STAT. He covers Wall Street and biotechnology.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.statnews.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Archives for Adam Feuerstein\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.statnews.com\/#website\",\"url\":\"https:\/\/www.statnews.com\/\",\"name\":\"STAT\",\"description\":\"A decade of reporting from the frontiers of health and medicine\",\"publisher\":{\"@id\":\"https:\/\/www.statnews.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.statnews.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.statnews.com\/#organization\",\"name\":\"STAT\",\"url\":\"https:\/\/www.statnews.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.statnews.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.statnews.com\/wp-content\/uploads\/2016\/06\/Stat_Logo_150.png\",\"contentUrl\":\"https:\/\/www.statnews.com\/wp-content\/uploads\/2016\/06\/Stat_Logo_150.png\",\"width\":150,\"height\":41,\"caption\":\"STAT\"},\"image\":{\"@id\":\"https:\/\/www.statnews.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/statnews\/\",\"https:\/\/x.com\/statnews\",\"https:\/\/www.linkedin.com\/company\/stat-news\/\",\"https:\/\/www.youtube.com\/channel\/UC89FjSf9AT1O2qw6vxrrxDQ\"],\"description\":\"STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories from the places that matter to our readers \u2014 research labs, hospitals, executive suites, and political campaigns.\",\"legalName\":\"STAT\",\"foundingDate\":\"2015-11-01\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"51\",\"maxValue\":\"200\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.statnews.com\/#\/schema\/person\/5a990e144a5ebf7a9bef3a36e270ab01\",\"name\":\"Adam Feuerstein\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.statnews.com\/#\/schema\/person\/image\/776c26a0da486c5e63e432e7bb4549cf\",\"url\":\"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-96x96.png\",\"contentUrl\":\"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-96x96.png\",\"caption\":\"Adam Feuerstein\"},\"description\":\"Adam Feuerstein is a senior writer and biotech columnist for STAT, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a cohost of STAT's weekly \\\"The Readout LOUD\\\" podcast and the author of the weekly newsletter Adam's Biotech Scorecard. In 2022, a series of stories by Feuerstein and STAT colleagues that examined Biogen and the controversial approval of its Alzheimer's disease drug Aduhelm won the George Polk Award for medical reporting, and NIHCM and SABEW journalism prizes. Prior to joining STAT in 2017, Feuerstein was a longtime biotech reporter at TheStreet, a biotech analyst for a New York investment fund, and covered the early internet and dot-com era as a San Francisco-based technology reporter. You can reach Adam on Signal at stataf.54.\",\"sameAs\":[\"https:\/\/x.com\/adamfeuerstein\"],\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Adam Feuerstein, Senior Biotech Writer","description":"Adam Feuerstein is a senior writer, biotech columnist and podcast host for STAT. He covers Wall Street and biotechnology.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/","og_locale":"en_US","og_type":"profile","og_title":"Adam Feuerstein","og_url":"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/","og_site_name":"STAT","og_image":[{"width":1000,"height":576,"url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-1000x576.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@statnews","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"ProfilePage","@id":"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/","url":"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/","name":"Adam Feuerstein, Senior Biotech Writer","isPartOf":{"@id":"https:\/\/www.statnews.com\/#website"},"description":"Adam Feuerstein is a senior writer, biotech columnist and podcast host for STAT. He covers Wall Street and biotechnology.","breadcrumb":{"@id":"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.statnews.com\/staff\/adam-feuerstein\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.statnews.com\/"},{"@type":"ListItem","position":2,"name":"Archives for Adam Feuerstein"}]},{"@type":"WebSite","@id":"https:\/\/www.statnews.com\/#website","url":"https:\/\/www.statnews.com\/","name":"STAT","description":"A decade of reporting from the frontiers of health and medicine","publisher":{"@id":"https:\/\/www.statnews.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.statnews.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.statnews.com\/#organization","name":"STAT","url":"https:\/\/www.statnews.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.statnews.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2016\/06\/Stat_Logo_150.png","contentUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2016\/06\/Stat_Logo_150.png","width":150,"height":41,"caption":"STAT"},"image":{"@id":"https:\/\/www.statnews.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/statnews\/","https:\/\/x.com\/statnews","https:\/\/www.linkedin.com\/company\/stat-news\/","https:\/\/www.youtube.com\/channel\/UC89FjSf9AT1O2qw6vxrrxDQ"],"description":"STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories from the places that matter to our readers \u2014 research labs, hospitals, executive suites, and political campaigns.","legalName":"STAT","foundingDate":"2015-11-01","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"51","maxValue":"200"}},{"@type":"Person","@id":"https:\/\/www.statnews.com\/#\/schema\/person\/5a990e144a5ebf7a9bef3a36e270ab01","name":"Adam Feuerstein","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.statnews.com\/#\/schema\/person\/image\/776c26a0da486c5e63e432e7bb4549cf","url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-96x96.png","contentUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2021\/02\/adam-f-profile-96x96.png","caption":"Adam Feuerstein"},"description":"Adam Feuerstein is a senior writer and biotech columnist for STAT, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a cohost of STAT's weekly \"The Readout LOUD\" podcast and the author of the weekly newsletter Adam's Biotech Scorecard. In 2022, a series of stories by Feuerstein and STAT colleagues that examined Biogen and the controversial approval of its Alzheimer's disease drug Aduhelm won the George Polk Award for medical reporting, and NIHCM and SABEW journalism prizes. Prior to joining STAT in 2017, Feuerstein was a longtime biotech reporter at TheStreet, a biotech analyst for a New York investment fund, and covered the early internet and dot-com era as a San Francisco-based technology reporter. You can reach Adam on Signal at stataf.54.","sameAs":["https:\/\/x.com\/adamfeuerstein"],"mainEntityOfPage":{"@id":"https:\/\/www.statnews.com\/staff\/adam-feuerstein\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/users\/263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.statnews.com\/wp-json\/wp\/v2\/users"}]}}